Chapter 3. Uses and Growth of Hematopoietic Cell Transplantation

  1. Frederick R. Appelbaum MD Member Director Professor Head2,3,
  2. Stephen J. Forman MD Director Staff Physician4,5,
  3. Robert S. Negrin MD Professor of Medicine Chief6 and
  4. Karl G. Blume MD, FACP Emeritus Professor of Medicine6,7
  1. Mary M. Horowitz MD, MS Chief Scientific Director

Published Online: 5 MAR 2009

DOI: 10.1002/9781444303537.ch3

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

How to Cite

Horowitz, M. M. (2009) Uses and Growth of Hematopoietic Cell Transplantation, in Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition (eds F. R. Appelbaum, S. J. Forman, R. S. Negrin and K. G. Blume), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303537.ch3

Editor Information

  1. 2

    Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

  2. 3

    Division of Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA

  3. 4

    Department of Hematology and Hematopoietic Cell Transplantation, Duarte, California, USA

  4. 5

    Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California, USA

  5. 6

    Division of Blood and Marrow Transplantation, Stanford University, Stanford, California, USA

  6. 7

    Division of Bone Marrow Transplantation, Department of Medicine, Stanford University, School of Medicine, Stanford, California, USA

Author Information

  1. Center for Blood and Marrow Transplant Registry (CIBMTR), Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Publication History

  1. Published Online: 5 MAR 2009
  2. Published Print: 27 FEB 2009

ISBN Information

Print ISBN: 9781405153485

Online ISBN: 9781444303537

SEARCH

Keywords:

  • hematopoietic cell transplantation - uses and growth;
  • diseases and autologous and/or allogeneic hematopoietic cell transplants;
  • changing indications for HCT;
  • allogeneic hematopoietic cell transplantation and congenital immune deficiency diseases;
  • autologous transplantation;
  • transplantation regimens and supportive care;
  • calcineurin inhibitor cyclosporine (CSP);
  • cytomegalovirus (CMV) disease prevention through CMV-negative

Summary

This chapter contains sections titled:

  • Introduction

  • Changing indications for HCT

  • Hematopoietic cell sources

  • Transplantation regimens and supportive care

  • Long-term survivors

  • Assessing and improving results of HCT

  • References